IgG Subclass Deficiency
Understanding IgG Subclass Deficiency
Subclass deficiency is characterized by a deficiency in one or more of the four immunoglobulin G subclasses (IgG1, IgG2, IgG3 and IgG4), which may result in an increased susceptibility to infections. IgG subclass deficiency affects only IgG subclasses (typically one or two subclasses), with normal total immunoglobulin type G (IgG), immunoglobulin type M (IgM) and other components of the immune system.
Symptoms of IgG Subclass Deficiency
As with other primary immune deficiencies common symptoms include frequent infections requiring treatment with antibiotics.
Diagnosing IgG Subclass Deficiency
Both males and females can be affected and there has been no pattern of inheritance observed in the IgG subclass deficiencies. An IgG subclass deficiency discovery should prompt evaluations over a period of months before determining whether a patient is truly immunodeficient. Subclass deficiencies need to be carefully interpreted considering the clinical status of the patient and their ability to produce certain antibodies in response to vaccines. Diagnosis includes serial testing of total IgG and IgG subclasses and testing of immune response to vaccines.
Treating IgG Subclass Deficiency
The use of antibiotics to treat and prevent infections is standard treatment for patients with subclass deficiency, as well as additional immunization with pneumococcal vaccines to assist with immunity. Immune globulin replacement therapy is a recommended for patients that have persistent IgG subclass deficiencies, poor responses to polysaccharide vaccines and fail prophylactic antibiotic therapy. Immune globulin therapy can be administered into the blood stream intravenously (IVIG) or under the skin subcutaneously (SCIG).
This content is not intended to substitute professional medical advice. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
At Nufactor, we are committed to providing our patients the education, support and resources necessary to complete your IVIG treatment successfully and with the desired outcomes. Please contact us with any further questions.